Introduction
Thiazide diuretics have been used in the treatment of hypertension since the introduction of chlorothiazide in 1957. The mode of action is obscure, but is probably unrelated to the natriuretic effect (Maronde, Milgrom & Dickey, 1969; Dollery et aL, 1962 ) and may be due to relaxation of arteriolar smooth muscle. Whilst thiazides have few clinically evident side-effects, it is commonly held that hypokalaemic alkalosis, carbohydrate intolerance and hyperuricaemia are frequent unwanted effects. The thiazides are most frequently used as an adjunct to more potent antihypertensive drugs.
Patients and methods
Two hundred and twenty-seven patients with moderate to severe hypertension (eighty-nine males, average age 52 6, 138 females, average age 52-3) were treated with a thiazide diuretic alone-usually hydroflumethiazide-and followed for periods of up to 12 years. This number does not include those hypertensives who required additional antihypertensive agents within a few months of starting thiazide therapy. The patients underwent conventional investigations in order to determine the aetiology of their hypertension (Table 1) . The mode of presentation and complications at presentation (Table 2) were the same as commonly found in any group of hypertensives, the proportion (Hamilton, 1966) . Patients were generally treated on an out-patient basis and seen within 6-weekly intervals until adequate blood pressure control was achieved, thereafter they were seen at 4-6-monthly intervals.
All underwent routine clinical examination, their urine was tested and they had regular checks of their blood urea and electrolytes. Ninety-six cases had their serum uric acid checked on several occasions. The duration of follow-up is shown in Fig. 1 .
Eleven cases were referred to us whilst on other anti-hypertensive agents which had failed to control their hypertension. In these cases an untreated blood pressure level was not available.
The majority (71%Y) of patients were treated with 200 mg of hydroflumethiazide (Hydrenox, Boots). The remainder received smaller doses, and a few had other thiazide diuretics in equivalent doses. Potassium supplements were recommended as a routineusually slow K (Ciba) in a dose of 1-2 tablets daily (600-1200 g daily), but 22%Y were given increasing doses if their serum potassium fell to very low levels. In eight cases the thiazide was given on 5 days in 7 in an attempt to lessen the hypokalaemic effect.
Results

Bloodpressure control
The mean and standard error, and 95°/ confidence interval for the mean blood pressure before and when receiving treatment are shown in Fig. 2 and Table 3 . Good control (diastolic blood pressure less than 100 mmHg) was maintained in 50%/, fair control (diastolic blood pressure less than 110 mmHg) in 35%/ and poor control (diastolic blood pressure more than 110 mmHg) in only 15%. In all fifty-six of the 227 cases (20 2%) eventually required the addition of a more potent agent, and the time when this became necessary is shown in Fig Complications of hypertension Those patients in whom the blood pressure became uncontrolled were given additional antihypertensive therapy and it is in this group that complications of hypertension are most likely to develop. The incidence of complications developing whilst on thiazides alone is shown in Table 4 .
At the start of treatment thirty-four patients had a raised blood urea, but the majority did not show a rise. Six patients developed significant renal failure, but all had underlying renal disease.
Hypokalaemia
There was a marked fall in the plasma potassium in most cases as shown in Fig. 3 which compares the pre-treatment plasma potassium with the average of 
Hyperuricaemia and gout
Four patients (1 7%) developed clinical gout with hyperuricaemia and one other developed an arthropathy with a normal serum uric acid. Those patients with gout were effectively treated with allopruinol or probenecid. Ninety-six patients had their serum uric acid estimated and eighteen of these were greater than 7 0 mg/100 ml giving an incidence of hyperuricaemia of 18% of estimations.
In no cases was it necessary to discontinue therapy on account of side-effects of thiazide diuretics.
Discussion
In the majority of the 227 patients who were maintained on thiazide diuretics for up to 12 years, it was possible to achieve good control of the blood pressure with no symptoms attributable to the administration of the drugs except a low incidence of diabetes and gout. The patients in this report all had a severe manometric hypertension with mean pretreatment levels of blood pressure of 203-4 mmHg systolic and 1206 mmHg diastolic, and many had either symptoms or objective complications of raised arterial pressure (Table 2 ). In spite of this the majority were adequately controlled, without recourse to more potent anti-hypertensive agents. The incidence of complications of hypertension whilst on treatment is low (Table 4) , although this is partly because those patients in whom the blood pressure became uncontrolled were given additional drugs and are no longer considered. However, it is interesting to note that, as during therapy with other drugs, the blood pressure may go out of control even after years on thiazides (Fig. 5) . The incidence of sideeffects of thiazide drugs, e.g. diabetes and gout, was low, and no patient required to discontinue therapy.
These results compare well with other trials from this clinic with methyldopa (Hamilton, 1968) and clonidine (Kellett & Hamilton, 1969) , in which there were a higher incidence of side-effects and an appreciable number of treatment failures.
Direct comparison of the adequacy of control of blood pressure is not possible, as in the other trials there was a larger proportion of patients with more severe hypertension including some who had failed to respond to thiazides initially.
We have used high doses of thiazides in most cases as it was found at the beginning of the period of observation that patients who showed a poor response to small doses initially, often responded to a higher dose. This is contrary to the findings of other workers who demonstrated a flat doseresponse curve in a short term investigation (Cranston et al., 1963) . However, the antihypertensive effect of the majority of drugs is augmented by an increased dose.
Hypokalaemia occurs almost invariably, may be profound, and is persistent, often despite large doses of potassium supplement. In view of the absence of symptoms attributable to hypokalaemia here and elsewhere (Maronde etal., 1969) it has been suggested that potassium supplements are unnecessary (Healy et al., 1970) . We have used potassium supplements as a routine because many patients may subsequently require digitalis therapy or develop an acute potassium-losing condition (e.g. gastro-enteritis) which might precipitate a serious hypokalaemia. Large quantities of potassium supplements are inconvenient and may in themselves give rise to side-effects and trials are being performed on potassiumretaining agents. There is no doubt that a marked metabolic alkalosis also occurs, sometimes even when the plasma potassium is within the lower range of accepted normal: when potassium supplements are increased the alkalosis is usually reversed, and it is possible that the degree of alkalosis is a better measure of the total body content of potassium than is a simple measure of the plasma potassium, especially as potassium is mainly an intracellular ion.
The incidence of thiazide-induced diabetes was lower than commonly reported, although a similar incidence has been found elsewhere (Kohler et al., 1970) . Furthermore, the two patients who were diabetic before starting treatment did not require any additional anti-diabetic drugs and none of the patients in either group required insulin. Great emphasis is placed in weight reduction in obese hypertensives, which is also an effective means of treating maturity-onset obese diabetics. We have found a lower incidence of hyperuricaemia than has been reported elsewhere. Breckenridge (1966) reported hyperuricaemia in 58% of hypertensives on treatment and in 27% of untreated hypertensives, although he used slightly different criteria of normal, and also more patients had impaired renal function. Clinical gout was rare (1 7%) in this survey and provided the blood pressure is well controlled, it is desirable to treat the gout and continue the thiazides.
